Enhancement of tumor antigen expression and inhibition of pulmonary metastasis of rat fibrosarcoma cells by local radiotherapy

Anticancer Research

Volumn 17, Issue 1 A, 1997, Pages 317-322

  Shibata, Toshiyuki ^a   Hosokawa, Masuo ^b   Micallef, Mark ^b   Chiba, Itsuo ^b   Mizukoshi, Takanori ^b   Kato, Motoyasu ^a   Takeichi, Noritoshi ^b   Kobayashi, Hiroshi ^b  

^a HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Antigen shedding; Irradiation; Local radiotherapy; Tumor associated antigen

Indexed keywords

COBALT 60; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CELL SURFACE; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; FIBROSARCOMA; LUNG METASTASIS; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RAT; SPLEEN CELL; TUMOR GROWTH;

ANIMALS; ANTIGENS, NEOPLASM; FEMALE; FIBROSARCOMA; LUNG NEOPLASMS; RATS;

EID: 0031051157     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Markus MH, Heike A, Klaus UG, Ilona F, Rudoluf B, Karl-Walter J, Friedrich WS: Individual development and uPA-receptor expression of disseminated tumour cells in hone marrow: A reference to early systemic disease in solid cancer. Nature Medicine 1: 1035-1039, 1995.
2. Osborn MP and Rosen PP: Detection and management of bone marrow micrometastasis in breast cancer. Oncology 8: 25-31, 1994.
3. Lindeman F, Schlimok G, Dirschedl P, Witte I, Riethmueller G: Prognostic significance of micrometastatic tumor cells in bone marrow of colorectal cancer patients. Lancet 340: 685-689, 1992.
4. Hosokawa M, Xu Z-Y, Morikawa K, Hamada J and Kobayashi H: Host immune response to tumor cells augmented by bleomycin and their therapeutic effects on rat fibrosarcoma. Mol Biother 1: 74-80, 1988.
5. Morikawa K, Hosokawa M, Hamada J, Sugiura M and Kobayashi H: Host-mediated therapeutic effects produced by appropriately timed administration of bleomycin on a rat fibrosarcoma. Cancer Res 45: 1502-1506, 1985.
6. Morikawa K, Hosokawa M, Hamada J, Xu Z-Y and Kobayashi H: Possible participation of tumoricidal macrophages in the therapeutic effect of bleomycin on a transplantable rat fibrosarcoma. Cancer Res 46: 684-688, 1986.
7. Akiyama J, Kawamura T, Gotohda E, Yamada Y, Hosokawa M, Kodama T and Kobayashi H: Immunochemotherapy of transplantaed KMT-17 tumor in WKA rats by combination of cyclophosphamide and immunostimulatory protein-bound polysaccharide isolated from basidiomycetes. Cancer Res 37: 3042-3045, 1977.
8. Chiba I, Ren J, Hamada J, Hosokawa M, Takeichi N and Kobayashi H: Growth-associated shedding of a tumor antigen (CE7) deteceted by a monoclonal antibody. Cancer Res 49: 3972-3975, 1989.
9. Micallef M, Shibata T, Hosokawa M and Kobayashi H: Bleomycin but not its derivatives inhibits the in vivo shedding of a rat tumor-associated antigen. Anti-Cancer Drugs 3: 659-664, 1992.
10. Shibata T, Micallef M, Chiba I, Hosokawa M and Kobayashi H: Modulation of the shedding of a rat tumor-associated antigen by growth regulation and anti-cancer drugs. Anti-Cancer Drugs 4: 657-664, 1993.
11. Shibata T, Hosokawa M, Micallef M, Mizukoshi T, Ren J, Chiba I, Takeichi N and Kobayashi H Modulation of the rat tumor-associated shedding antigen (CE7) and augmentation of immunogenicity by irradiation. Anticancer Res 16: 99-104, 1996.
12. Yamashita T, Hayakawa K, Hosokawa M, Kodama T, Inoue N, Tomita K and Kobayashi H: Enhanced tumor metastasis in rats following cryosurgery of primary tumor. Gann 73: 222-228, 1982.
13. Micallef M, Hosokawa M, Shibata T, Nakane A, Yang Z, Minagawa T and Kobayashi H: Immunoregulatory cytokine release in rat spleen cell cultures after treatment with bleomycin and its analogues in vivo Cancer Immunol Immunother 33: 33-38, 1991.
14. LoFrancois D, Troise GD, Chavaurda N, Malaise EP and Barski G: Comparative effect of local radiotherapy and surgery on cell-mediated immunity against a mouse transplantable mammary tumor. Int J Cancer 13: 629-639, 1974.
15. Moroson H, Npwakonski J and Schechter M: Enhanced lymphocytemediated killing of tumor cells after tumour irradiation in vivo. Int J Radiat Biol 33: 473-482, 1978.
16. Gerber M, Dubois JB, Pioch Y and Scrrou B: Effects of localized radiotherapy upon the cellular immune response. Radiat Res 85: 390-398, 1981.
17. Alexander P: Escape from immune destruction by the host through shedding of surface antigens: Is this a characteristic shared by malignant and embryonic cells? Cancer Res 34: 2077-2082, 1974.
18. Herlyn M, Guerry D and Koprowski H: Recombinant γ-interferon induces changes in expression and shedding of antigens associated with normal human melanocytes, nevus cells, and primary and metastatic melanoma cells. J Immunol 134: 4226-4230, 1985.
19. Kodama Y, Ochiai H, Shimizu K, Azuma E, Kamiya H and Sakurai M: Shedding of leukemia-associated P24 antigen by lymphoblastoid cell lines. Jpn J Clin Oncol 17: 333-342, 1987.
20. Ladisch S, Kitada S and Hays EF: Gangliosides shed by tumor cells enhance tumor formation in mice. J Clin Invest 79: 1879-1882, 1987.
21. Giacomini P, Aguzzi A, Pestka S, Fisher PB and Ferrone S: Modulation by recombinant DNA leukocyte (α) and fibroblast (β) interferons of the expression and shedding of HLA- and tumor-associated antigens by human melanoma cells. J Immunol 133: 1649-1655, 1984.
22. Taylor DD and Black PH Inhibition of macrophage la antigen expression by shed plasma membrane vesicles from metastatic murine melanoma lines. JNCI 74: 859-867, 1985.
23. Taylor DD, Taylor CG, Jiang C, Black PH Characterization of plasma membrane shedding from murine melanoma cells. Int J Cancer 41: 629-635, 1988.
24. Barz D, Goppelt M, Szamel M, Schirrmacher V and Resch K: Characterization of cellular and extracellular plasma membrane vesicles from a non-metastasizing lymphoma (Eb) and its metastasizing variant (ESb). Biochimica et Biophysica Acta 814: 77-84, 1985